topics / erythropoietin

Tagged erythropoietin.

Preliminary human ARA-290 (Cibinetide): A Non-Blood-Building EPO Fragment With Early, Conflicted Human Data ARA-290 is an investigational EPO-derived peptide studied for nerve injury. Real but small, short, developer-run trials exist — no Phase 3 and no approval.